Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhether to increase your Mounjaro dose is a clinical decision, not a personal one. The licensed titration schedule exists to give your body time to adjust, and moving up before that adjustment is complete often brings more side effects without extra benefit. Your prescriber, not a timetable on paper, decides when you are ready. Here is what the guidance actually says, and what to expect at each stage.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is one of the most common things our prescribers encounter, the idea that a higher dose is simply a better dose, and that staying at 2.5 mg or 5 mg is somehow holding you back. That is understandable. When you start treatment hoping for results, a lower number on the pen can feel like it is not doing enough.
The reality is more straightforward. Tirzepatide's titration schedule, as set out in the licensed summary of product characteristics on the eMC (Medicines Compendium), exists precisely because the gut-hormone pathways Mounjaro acts on need time to recalibrate. The first dose exists to settle your system, nausea, burping, loose stools and fatigue are common in the early weeks because your body is adjusting to slowed gastric emptying and a sharp change in appetite signalling. Rushing past that phase tends to compound those effects rather than skip them.
So the question is not really whether to increase your Mounjaro dose as quickly as possible. It is whether, at this moment, your body has settled enough and your prescriber agrees there is clinical reason to move up. Those are two different things, and only one of them is yours to answer.
Four weeks at a given dose is the minimum, not a guarantee. A prescriber reviewing a dose increase will want to know several things: how well you are tolerating your current strength, whether the gastrointestinal effects (nausea, vomiting, diarrhoea, constipation, reflux) have largely settled, how your weight has trended, and whether any new symptoms have appeared. If GI effects are still frequent or disruptive, most clinicians will advise staying put rather than moving to the next step.
The NHS's patient information on tirzepatide notes that dose increases should follow clinical assessment; they are not automatic on a fixed monthly calendar. That is a significant distinction. Someone who has had a difficult four weeks may need eight before a step up is sensible. Someone who has sailed through the starter dose may move sooner. There is no universal answer.
Weight loss velocity is one data point, not the whole picture. Some people lose steadily on earlier doses; others plateau and then see bigger changes after a step up. A prescriber considers all of this in context rather than acting on any single figure. If you are wondering specifically about the move from 2.5 mg to 5 mg, the same principles apply, tolerability first, then trajectory.
Tell your prescriber. That sounds obvious, but a lot of people sit on the question and wait to be asked rather than raising it themselves. If four weeks have passed, your side effects have settled, and you are not losing weight or feel appetite suppression has plateaued, that is exactly the conversation to have at your next review.
At the same time, it is worth giving the current dose a fair test. Appetite suppression from tirzepatide often deepens over several weeks as the medicine reaches steady state in your bloodstream. Some patients who felt very little in week two notice a clear shift by week five or six without any dose change. Jumping to the next level before that has had a chance to happen means you may never know what that dose could have done.
For those already at 5 mg and wondering whether 7.5 mg is the right next step, or further on in the schedule considering moving to 10 mg, the logic is the same at every stage. The prescriber's job is to match your dose to your clinical picture, not to a generic schedule. If you want to understand more about what each strength is designed to do, the 5 mg guide and the wider Mounjaro overview cover the specifics in plain terms.
It is also worth knowing that the cost of treatment does shift as doses increase, so if you are at an earlier stage and budget is part of your thinking, the Mounjaro pricing page sets out how that works honestly. And if you have other questions about the process, our FAQs cover a lot of the common ground.
If you are ready to have the dose conversation properly, speak to our prescribers, a real clinician reviews your consultation the same day, and every repeat supply goes through that same check.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.